PML and central nervous system cancer: Despite the complex mutational background of these cells, a single copy of H3.3 K27M was sufficient to cause a marked decrease in PML-NBs in the H3.3 K27M glioma cells compared to the H3.3 WT (K27M KO) controls (Fig. 3A–C).